CROs/Service Providers

The CenterWatch Monthly, March 2012

Thursday, March 1, 2012 06:05 AM

Living in a post-M&A world of CROs

More... »

Quintiles and RCV Biofund to expand clinical development capabilities in Russia

Monday, February 27, 2012 09:56 AM

Quintiles and Russian Venture Company (RVC) Biofund, a Russian-based investment firm, have joined to support expansion of clinical development services within the Russian Federation, the world's ninth most populous country.

More... »

CRO Frontage and Fanghui Pharma launch collaboration

Thursday, February 23, 2012 02:42 PM

An emerging Chinese pharmaceutical company just launched a new globalization strategy by tapping the pharmaceutical R&D, manufacturing, registration and marketing expertise of global CRO Frontage Laboratories.

More... »

Premier Research expands in Salt Lake City and Phoenix

Thursday, February 23, 2012 02:39 PM

CRO Premier Research Group is opening state-of-the-art clinical research facilities in Phoenix, Ariz., and Salt Lake City, Utah, increasing its testing facilities capacity by 50%.
 
“We are excited to be expanding our existing clinical research facilities to accommodate more phase I and outpatient studies,” stated Michael Kuss, vice president, analgesia, Premier Research.

More... »

Venn Life Sciences and Encorium to merge

Wednesday, February 22, 2012 01:57 PM

Finland-based CRO Encorium Group and Venn Life Sciences, a provider of development consulting and resourcing services based in Dublin, Ireland, have agreed to merge.

More... »

ICON reports quarterly revenue up 5%

Friday, February 17, 2012 01:43 PM

ICON,a global CRO, has reported financial results for the full year and for the fourth quarter ending Dec. 31, 2011.

More... »

Charles River posts quarterly and full-year 2011 results

Friday, February 17, 2012 01:40 PM

Charles River Laboratories has reported financial results for the fourth quarter and for full-year 2011.

More... »

Almac doubles analytical capacity, adds 10 jobs

Wednesday, February 15, 2012 02:59 PM

Almac is doubling its analytical capacity at its North American headquarters in Souderton, Penn., increasing the number of employed scientists from 10 to 20.

More... »

Quintiles launches strategic drug development and consulting services in Asia

Tuesday, February 14, 2012 11:52 AM

To help biopharmaceutical companies navigate the complexities of the Asia market, Quintiles has launched two services—Strategic Drug Development and Consulting at Quintiles—to bolster the probability of success in developing and commercializing new medications in the region.

More... »

Quintiles expands commercial services in Middle East and North Africa

Tuesday, February 14, 2012 11:42 AM

Quintiles is extending its global footprint to provide commercial services in the Middle East and North Africa (MENA) region through an agreement with Dayarn Pharma, a United Arab Emirates (UAE)-based company that specializes in biopharmaceutical sales, marketing and regulatory efforts needed to maximize brands in the Arab Gulf region.

More... »